Agucare 與 MCSAID 使用情況與統計

It is a safe, user-friendly telemedicine platform that creates a direct channel between the health professional and the patient, with all the necessary functionalities to be able to carry out a correct consultation and follow-up of the patient's treatment. It is an indispensable tool in the new form of doctor-patient relationship. Among the main functionalities considered are: video calls for teleconsultation, direct chat between doctor-patient that maintains the privacy and confidentiality of face-to-face care; generation of medical orders for procedures / exams and prescriptions, record of care per patient, personalized system of notifications of continuity of treatment.
  • Google Play 商店
  • 免費版
  • 醫療

商店排名

- -

MCSAID is an educational application dedicated to the topic of mechanical cardiocirculatory support for patients with cardiogenic shock. A basic section introduces the definitions and classifications of cardiogenic shock as well as some of the common devices used for hemodynamic support in unstable patients. There is an algorithm for helping understand the decision process depending on key clinical variables such as cardiac output and PAPI. There are also several weaning and escalation algorithm. A calculator section is available for some common hemodynamic variables used in MCS decision-making and is available for quick-reference throughout the algorithm. MCSAID is an educational application for medical professionals and is not intended for making medical diagnoses. Medical decisions must be made by licensed professionals with the entire context of a patient’s medical history. If you are seeking a medical diagnosis, contact your physician and if you are experiencing a medical emergency, call your local emergency medical services.
  • Google Play 商店
  • 免費版
  • 醫療

商店排名

- -

Agucare與 MCSAID 比較排名

比較過去 28 天的 Agucare 排名趨勢與 MCSAID

排名

無可用數據

各國 Agucare vs. MCSAID 排名比較

比較過去 28 天的 Agucare 排名趨勢與 MCSAID

所有類別

無可用數據

醫療

應用程式
頂級國家
排名
#39
- -
- -

使用我們的免費試用版,與所有網站進行比較

立即開始
Agucare VS.
MCSAID

12月 9, 2024